TLDR Omalizumab can cause temporary hair loss but still works well for chronic urticaria.
Omalizumab, an anti-IgE medication used for chronic urticaria, was associated with several common adverse effects, including headache and fatigue. Recently, there were reports of hair loss as a side effect. A case was described involving a young female who experienced transient hair loss after starting omalizumab. Despite this, she continued the treatment for 10 months and experienced positive outcomes.
101 citations
,
January 1997 in “Journal of Investigative Dermatology Symposium Proceedings” Nerves and chemicals in the body can affect hair growth and loss.
59 citations
,
June 2022 in “Frontiers in medicine” There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.
1 citations
,
March 2024 in “BioDrugs” Biologics for severe asthma have known side effects, but some new risks need more study.
1 citations
,
May 2023 in “Prospects in Pharmaceutical Sciences” New cytokine-targeted therapies show promise for treating alopecia areata.
January 2025 in “International Journal of Molecular Sciences” Psoriasis involves immune and genetic factors, and understanding these can improve treatments.
2 citations
,
October 2022 in “Current Allergy and Asthma Reports” Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.
